Novel recombinant human thrombopoietin analogues having enhanced in vivo activity.

被引：0
|
作者：
Lim, SW [1 ]
Park, SK [1 ]
Park, J [1 ]
Ahn, HK [1 ]
Ju, SM [1 ]
Chang, WIK [1 ]
Chung, JY [1 ]
Koh, YW [1 ]
Park, SK [1 ]
机构：
[1] Daewoong Pharm Co Ltd, R&D Ctr, Kyunggi Do, South Korea
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3956
引用
收藏
页码：175B / 175B
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic profiles of novel recombinant human thrombopoietin analogues compared with natural recombinant human thrombopoietin.
    Lim, SW
    Park, SK
    Ahn, HK
    Park, JS
    Koh, YW
    Park, SK
    BLOOD, 2000, 96 (11) : 155B - 155B
  • [2] Recombinant human thrombopoietin: Clinical experience and in vivo biology
    Vadhan-Raj, S
    SEMINARS IN HEMATOLOGY, 1998, 35 (03) : 261 - 268
  • [3] Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity
    Perot, Eloise
    Enjolras, Nathalie
    Le Quellec, Sandra
    Indalecio, Alice
    Girard, Jonathan
    Negrier, Claude
    Dargaud, Yesim
    THROMBOSIS RESEARCH, 2015, 135 (05) : 1017 - 1024
  • [4] A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy
    Kong, Zhangyuan
    Qin, Ping
    Xiao, Shan
    Zhou, Hai
    Li, Hong
    Yang, Renchi
    Liu, Xiaofan
    Luo, Jianmin
    Li, Zhichun
    Ji, Guochao
    Cui, Zhongguang
    Bai, Yusheng
    Wu, Yuxia
    Shao, Linlin
    Peng, Jun
    Ma, Jun
    Hou, Ming
    BLOOD, 2017, 130 (09) : 1097 - 1103
  • [5] Recombinant human prolactin is an antagonist of TGF-beta activity.
    Richards, SM
    Keyes, L
    Kavanagh, B
    OBrien, M
    McPherson, JM
    FASEB JOURNAL, 1996, 10 (06): : 2784 - 2784
  • [6] Synthesis and In vivo Antifibrotic Activity of Novel Leflunomide Analogues
    Hamdi, Abdelrahman
    Said, Eman
    Farahat, Abdelbasset A.
    El-Bialy, Serry A. A.
    Massoud, Mohammed A. M.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (09) : 912 - 920
  • [7] Development and validation of a novel reporter gene assay for determination of recombinant human thrombopoietin
    Yuan, Jie
    Li, Jia
    Yang, Lihua
    Lv, Yunying
    Wang, Chao
    Jin, Zheng
    Ni, Xianpu
    Xia, Huanzhang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [8] Recombinant Human Thrombopoietin: a Novel Therapeutic Option for Patients with Immune Thrombocytopenia in Pregnancy
    Kong, Zhangyuan
    Qin, Ping
    Wang, Xin
    Hou, Ming
    BLOOD, 2014, 124 (21)
  • [9] In vitro and In vivo Anticancer Activity of Novel Synthetic Makaluvamine Analogues
    Wang, Wei
    Rayburn, Elizabeth R.
    Velu, Sadanandan E.
    Nadkarni, Dwayaja H.
    Murugesan, Srinivasan
    Zhang, Ruiwen
    CLINICAL CANCER RESEARCH, 2009, 15 (10) : 3511 - 3518
  • [10] WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
    Faderl, S
    Estrov, Z
    Kantarjian, HM
    Fokt, I
    Harris, D
    Van, X
    Priebe, Q
    BLOOD, 1999, 94 (10) : 65A - 65A
12345